Protalix BioTherapeutics, Inc. 4
4 · Protalix BioTherapeutics, Inc. · Filed Oct 6, 2014
Insider Transaction Report
Form 4
Bronfeld Zeev
Director10% Owner
Transactions
- Other
Common Stock
2014-10-02+324,372→ 2,162,481 total - Other
Common Stock
2014-10-02−1,509,948→ 0 total(indirect: By Trust)
Footnotes (4)
- [F1]Biocell Ltd. distributed 1,509,948 shares of common stock of Protalix BioTherapeutics, Inc., in a dividend to its shareholders on a pro rata basis based on their respective percentage interests in Biocell Ltd. Biocell Ltd. is an Israeli public company traded on the Tel Aviv Stock Exchange Ltd.
- [F2]The shares were transferred to the Biocell Ltd. shareholders on a pro rata basis based on their respective percentage interests in Biocell Ltd. No consideration was paid in connection with the transfer.
- [F3]The reporting person, a shareholder of Biocell Ltd., received shares of Protalix BioTherapeutics, Inc. common stock pursuant to the dividend made by Biocell Ltd. described in this Form 4. The shares received are limited to the reporting person's percentage interest in Biocell Ltd. The reporting person continues to hold such shares.
- [F4]No consideration was paid in connection with the transfer.